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Purpose: The purpose of this study was to identify the disease-causing mutation and the molecular phenotype that are
responsible for the presence of an autosomal dominant congenital nuclear cataract disease in a Chinese family.
Methods: The family history and clinical data were recorded. The patients were given a physical examination and their
blood samples were collected for DNA extraction. Direct sequencing was used to detect the mutation. Transcription
analysis of the mutant crystallin, beta A1 (CRYBA1/A3) gene was performed to verify whether the defective mutation had
influenced the splice of the mature mRNA.
Results: The phenotype of the congenital cataract in the family was identified as a nuclear cataract type, by using slit-
lamp photography. Direct sequencing revealed a novel mutation IVS3+2 T→G in CRYBA1/A3. This mutation co-
segregated with all affected individuals in the family, but was not found in unaffected family members nor in the 100
unrelated controls. Transcription analysis of the mutant CRYBA1/A3 gene indicated that this mutation had influenced the
splice of the mature mRNA.
Conclusions: Our study identified a novel splice site mutation in CRYBA1/A3. This mutation was responsible for aberrant
splicing of the mature mRNA and had caused the congenital nuclear cataracts in the family. This is the first report relating
an IVS3+2 T→G mutation of CRYBA1/A3 to congenital cataracts.
Congenital cataract is a leading cause of poor vision or
blindness in children, which accounts for more than 1 million
blind  children  in  Asia  and  about  10%  of  the  childhood
blindness worldwide. Approximately 50% of all congenital
cataract cases may have a genetic cause [1-3]. These cataracts
are most frequently inherited as autosomal dominant traits,
but  can  also  be  inherited  in  other  forms  of  Mendelian
inheritance. Congenital cataract is a clinically and genetically
heterogeneous lens disorder [4]. According to morphology,
the cataracts can be classified into several subtypes: whole
lens, nuclear, lamellar, cortical, polar, sutural, pulverulent,
cerulean, coralliform, and other minor subtypes [5]. Cataracts
that are phenotypically identical can result from mutations at
different  genetic  loci  and  can  have  different  inheritance
patterns.  Conversely,  cataracts  with  dissimilar  phenotypes
may result from mutations in a single gene or a gene family.
To  date,  more  than  40  genetic  loci  have  been  linked  to
congenital cataracts, and at least 26 genes have been cloned
and sequenced, including crystallins, connexins, heat shock
transcription factor-4, aquaporin-0, and the beaded filament
structural  protein-2  [6].  Among  these  candidate  genes,
Correspondence  to:  Siquan  Zhu,  Beijing  Tongren  Eye  Center,
Beijing  Tongren  Hospital,  Capital  Medical  University,  Beijing
Ophthalmology & Visual Sciences Key Lab, 1 Dong Jiao Min Xiang,
Beiing  100730,  China;  Phone:  +8610-58269605;  Fax:
+8610-85110023; Email: siquanzhu@sina.com
crystallin  genes  and  connexin  genes  represent  a  major
proportion of the mutations identified in congenital cataract.
These  include  αA-crystallin  (CRYAA),  αB-crystallin
(CRYAB),  βA1/A3-crystallin  (CRYBA1/A3),  βB1-crystallin
(CRYBB1),  βB2-crystallin  (CRYBB2),  γC-crystallin
(CRYGC), γD-crystallin (CRYGD), γS-crystallin (CRYGS),
connexins46 (GJA3), and connexins50 (GJA8) [7].
In this study, we applied a functional candidate approach
to test the known crystallin and connexin genes in a Chinese
family.  A  novel  transversion  mutation  IVS3+2  T→G  in
CRYBA1/A3, which influences the splice of mature mRNA,
was detected.
METHODS
Clinical examination and isolation of genomic DNA: Data
reaching back for four generations of a Chinese Han family
with autosomal dominant congenital cataract was collected
from Beijing Tongren Hospital (Figure 1). Information on 100
normal controls was also collected from the Tongren Hospital.
The ethics committee of Capital Medical University approved
the research and all participants from the family gave their
informed consent. The study protocol followed the principles
of the Declaration of Helsinki.
A  history  of  cataract  extraction  or  ophthalmologic
examination was used to determine those whose status was
considered to be affected, and all participating members also
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1283underwent ophthalmic examination, including visual acuity,
slit-lamp examination, and intraocular pressure measurement.
The phenotypes were documented by slit-lamp photography,
and 5 ml of venous blood was collected in BD Vacutainers
(BD,  San  Jose,  CA)  containing  EDTA  from  participating
family members and controls. Genomic DNA was extracted
by  QIAamp  DNA  Blood  Mini  Kits  (Qiagen  Science,
Germantown, MD).
Mutation  detection:  All  coding  exons  and  the  flanking
splicing  junction  of  the  candidate  genes  known  to  be
associated  with  congenital  cataract,  including  CRYAA,
CRYAB, CRYBA1/A3, CRYBB2, CRYGC, CRYGD, CRYGS,
GJA3, and GJA8, were amplified by PCR with primers listed
in  Table  1.  Briefly,  PCR  amplification  conditions  were:
Reaction Mixture Set Up (50 μl); 2 μl (40 ng/ml) of DNA, 1.5
μl (10 μM) of each exon primer, 20 μl of water , and 25 μl of
PCR mix (2× EasyTaq PCR SuperMix; TransGen, Beijing,
China) in a final reaction volume of 50 μl. Thermal cycling
conditions were: an initial denaturation step at 95 °C for 5 min,
35 cycles (30 min at 95 °C, 30 min at 59°C, and 45min at 72
°C) and a final 10 min 72 °C extension. The PCR products
were  sequenced  from  both  directions  with  the  ABI  3730
automatic sequencer (PE Biosystems, Forster city, CA). The
sequencing results were analyzed using Chromas 2.33 and
compared to the reference sequences in the NCBI database.
Plasmid construction: DNA fragments extending from the
terminal DNA fragment of intron 2 to the tail end of exon 4
of CRYBA1 were amplified from the genomic DNA using the
primer couples CRYBA1-F (5′-CGG GGT ACC ATA ACC
ATC TAT GAT CAG GAG AAC-3′) and CRYBA1-R (5′-
CCG GAA TTC CTC AAT GTG GTA GGC ATT ACT C-3′).
PCR-amplified fragments carrying intron 3 and partial DNA
fragments of exon 3 and exon 4 were 1,992 bp. Purified PCR
products of CRYBA1 were inserted into digested pcDNA3.1
vectors. The mutant construction was also created through
PCR-mediated  site-directed  mutagenesis,  with  primers
CRYBA1-M-F (5′-AGT GGC GCG GGA GTA TGG ACT
TCC  G-3′)  and  CRYBA1-M-R  (5′-CCA  TAC  TCC  CGC
GCC ACT TTC CAC-3′). The wild-type and mutant plasmids
were confirmed and named as pc3.1-CYRBA1-wild-type (wt)
and pc3.1-CRYBA1 mutant-type (mt), respectively.
Cell culture and transfection: The 293T cells were maintained
in Iscove’s modified Dulbecco’s medium supplemented with
10% fetal bovine serum, 100 mg/ml penicillin and 100 mg/ml
strep-tomycin,  in  a  humidified  atmosphere  containing  5%
CO2 at 37 °C. The expression vectors pc3.1-CYRBA1-wt and
pc3.1-CYRBA1-mt were transfected into 293T cells using
Lipofectamine  2000  (Life  Technologies,  Carlsbad,  CA),
according to lipofection procedures.
RNA extraction and RT–PCR: The 293T cells were harvested
48 h after transfection. Total cellular RNA was extracted from
the  cells  using  the  TRIzol  Reagent  (Life  Technologies),
according to the manufacturer’s protocol. An RNA PCR kit
(TaKaRa, Dalian, China) was used to synthesize cDNA from
2 μg of RNA. After the RT reaction, the cDNA was amplified
by using the two pairs of primers that were used in the PCR
of the fragment DNA in CRYBA1. The amplified products
were separated by electrophoresis on 2% agarose gels.
Figure 1. A Chinese family that has had
autosomal dominant cataracts for four
generations. The black symbols indicate
individuals  who  have  been  given  a
diagnosis  of  congenital  cataracts  by
doctors.  The  arrow  indicates  the
proband. The asterisks indicate family
members who participated in this study.
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Clinical  evaluation:  Slit-lamp  examination  revealed
opacification of the nuclear cataracts (Figure 2).
Mutation analysis: Through direct gene sequencing of the
coding  regions  of  the  candidate  genes,  we  identified  an
IVS3+2 T→G substitution in the donor splice site of intron 3
in  CRYBA1/A3  in  all  affected  individuals  (Figure  3).
However,  we  did  not  find  this  mutation  in  any  of  the
unaffected family members nor in the 100 unrelated controls.
Indeed, we did not find any other mutations in this family,
Figure 2. Slit-lamp photographs of the right eyes of probands. Slit-
lamp examination revealed the opacity of the nuclear cataracts.
except  for  a  few  non-pathogenic  single  nucleotide
polymorphisms (SNPs).
Transcription analysis of the mutant CRYBA1/A3 gene: The
pc3.1-CYRBA1-wt  and  pc3.1-CYRBA1-mt  expression
vectors were transiently transfected into the 293T cells, to
verify  whether  CRYBA1  IVS3+2  T→G  substitution
influenced  the  splice  of  mature  mRNAs.  The  RT–PCR
products that were transfected from the 293T cells with pc3.1-
CYRBA1-wt showed a minor band, about 260 bp, indicating
that  exon  3-exon  4  were  combined,  except  for  intron3.
Meanwhile, those that were transfected from cells with pc3.1-
CYRBA1-mt showed a major band, about 1,992 bp, indicating
that exon 3-intron 3-exon 4 were combined (Figure 4A). The
result indicated that IVS3+2T→G in CRYBA1 led to incorrect
splicing of CRYBA1 mRNAs.
DISCUSSION
Lens crystallin is important in establishing and maintaining
lens  transparency  [8].  Previous  pedigree  and  transgenic
animal research have indicated that mutation in crystallin
genes would cause cataracts. Usually, the mutant crystallin
has altered the stability, solubility, or ability to oligomerize
and is predicted to precipitate from solution, which finally
results in lens opacity. In addition to their roles in transmitting
and focusing light, some lens crystallins have biochemical or
TABLE 1. THE PRIMMERS USED FOR PCR.
Exon Forward (5′-3′) Reverse (5′-3′)
CRYAA-1 5′-AGCAGCCTTCTTCATGAGC-3′ 5′-CAAGACCAGAGTCCATCG-3′
CRYAA-2 5′-GGCAGGTGACCGAAGCATC-3′ 5′-GAAGGCATGGTGCAGGTG-3′
CRYAA-3 5′-GCAGCTTCTCTGGCATGG-3′ 5′-GGGAAGCAAAGGAAGACAGA-3′
CRYAB-1 5‘-AACCCCTGACATCACCATTC-3′ 5′-AAGGACTCTCCCGTCCTAGC-3′
CRYAB-2 5′-CCATCCCATTCCCTTACCTT-3′ 5′-GCCTCCAAAGCTGATAGCAC-3′
CRYAB-3 5′-TCTCTCTGCCTCTTTCCTCA-3′ 5′-CCTTGGAGCCCTCTAAATCA-3′
CRYBA1–1 5′-GGCAGAGGGAGAGCAGAGTG-3′ 5′-CACTAGGCAGGAGAACTGGG-3′
CRYBA1–2 5′-AGTGAGCAGCAGAGCCAGAA-3′ 5′-GGTCAGTCACTGCCTTATGG-3′
CRYBA1–3 5′-AAGCACAGAGTCAGACTGAAGT-3′ 5′-CCCCTGTCTGAAGGGACCTG-3′
CRYBA1–4 5′-GTACAGCTCTACTGGGATTG-3′ 5′-ACTGATGATAAATAGCATGAACG-3′
CRYBA1–5 5′-GAATGATAGCCATAGCACTAG-3′ 5′-TACCGATACGTATGAAATCTGA-3′
CRYBA1–6 5′-CATCTCATACCATTGTGTTGAG-3′ 5′-GCAAGGTCTCATGCTTGAGG-3′
CRYBB2–1 5′-GTTTGGGGCCAGAGGGGAGTGGT-3′ 5′-TGGGCTGGGGAGGGACTTTCAGTA-3′
CRYBB2–2 5′-CCTTCAGCATCCTTTGGGTTCTCT-3′ 5′-GCAGTTCTAAAAGCTTCATCAGTC-3′
CRYBB2–3 5′-GTAGCCAGGATTCTGCCATAGGAA-3′ 5′-GTGCCCTCTGGAGCATTTCATAGT-3′
CRYBB2–4 5′-GGCCCCCTCACCCATACTCA-3′ 5′-CTTCCCTCCTGCCTCAACCTAATC-3′
CRYBB2–5 5′-CTTACCCTTGGGAAGTGGCAATGG-3′ 5′-TCAAAGACCCACAGCAGACAAGTT-3′
CRYGC-1 5′-TGCATAAAATCCCCTTACCG-3′ 5′-CCTCCCTGTAACCCACATTG-3′
CRYGC-2 5′-TGGTTGGACAAATTCTGGAAG-3′ 5′-CCCACCCCATTCACTTCTTA-3′
CRYGD-1 5′-CAGCAGCCCTCCTGCTAT-3′ 5′-GGGTCCTGACTTGAGGATGT-3′
CRYGD-2 5′-GCTTTTCTTCTCTTTTTATTTCTGG-3′ 5′-AAGAAAGACACAAGCAAATCAGT-3′
CRYGS-2 5′-GAAACCATCAATAGCGTCTAAATG-3′ 5′-TGAAAAGCGGGTAGGCTAAA-3′
CRYGS-3 5′-AATTAAGCCACCCAGCTCCT-3′ 5′-GGGAGTACACAGTCCCCAGA-3′
CRYGS-4 5′-GACCTGCTGGTGATTTCCAT-3′ 5′-CACTGTGGCGAGCACTGTAT-3′
GJA3–1 5′-CGGTGTTCATGAGCATTTTC-3′ 5′-CTCTTCAGCTGCTCCTCCTC-3′
GJA3–2 5′-GAGGAGGAGCAGCTGAAGAG-3′ 5′-AGCGGTGTGCGCATAGTAG-3′
GJA3–3 5′-TCGGGTTCCCACCCTACTAT-3′ 5′-TATCTGCTGGTGGGAAGTGC-3′
GJA8–1 5′-CCGCGTTAGCAAAAACAGAT-3′ 5′-CCTCCATGCGGACGTAGT-3′
GJA8–2 5′-GCAGATCATCTTCGTCTCCA-3′ 5′-GGCCACAGACAACATGAACA-3′
GJA8–3 5′-CCACGGAGAAAACCATCTTC-3′ 5′-GAGCGTAGGAAGGCAGTGTC-3′
GJA8–4 5′-TCGAGGAGAAGATCAGCACA-3′ 5′-GGCTGCTGGCTTTGCTTAG-3′
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chaperone function [9], and β-crystallin has been suggested
as having a role in anoikis [10]. The βγ-crystallins share a
highly stable structure comprising two domains joined by a
connecting peptide. Each domain includes motifs that form a
Greek  key  fold  forming  a  β-sandwich  structure.  The  γ-
crystallins are found as monomers, while the β-crystallins
associate into higher order complexes [11]. Most mutations
described in the βγ-crystallins would be expected to cause
major  abnormalities  in  the  protein  structure,  presumably
resulting in an unstable protein that precipitates from solution
and serves as a nidus for additional protein denaturation and
precipitation,  eventually  resulting  in  the  formation  of
cataracts.
CRYBA3/A1, located in 17q11.2, is a member of the β-
crystallin  family  and  consists  of  six  exons  encoding  two
Figure 3. Partial sequence of CRYBA1/
A3 at exon3. A: Sequence of affected
individual  (individual  III:11).  B:
Sequence  of  unaffected  individual
(individual  III:7).  In  panel  A,  the
heterozygous  mutation  IVS3+2  T→G
was  evident  at  the  flanking  splicing
junction. This was identified in all the
affected participants, but was not found
in unaffected family members or in the
100 unrelated control subjects.
Figure 4. Transcription analysis of the mutant CRYBA1/A3 gene. A: RT–PCR products separated on a 2% agarose gel. CRYBA1-wt (RT–
PCR products from the 293T cells transfected with pc3.1-CYRBA1-wt) showed a minor band, about 260 bp; CRYBA1-mt (RT–PCR products
from the 293Tells transfected with pc3.1-CYRBA1-mt) showed a major band, about 1,992 bp. B: Graphic presentation of wild and mutant
transcript, with the wild type indicating that exon 3-exon 4 were combined, except for intron 3, and the mutant transcript indicating that exon
3-intron 3-exon 4 were combined. C: Flank sequence of splice mutation. The red font indicates mutant base, the additional 24 amino acid
residues are marked by underline and the stop coden is marked by black frame.
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mRNA, through the use of an alternate translation initiation
site. βA1/A3-crystallin consists of seven protein regions: four
homologous (Greek key) motifs, a connecting peptide, and
NH2- and COOH-terminal extensions. The NH2-terminal arm
is encoded by the first two exons and the Greek key motifs are
encoded by exon3–exon6 [12]. βA3-crystallin is identical to
βA1-crystallin, except for 17 additional amino acid residues
found on its NH2-terminal arm [13].
So far, in the CRYBA1/A3 gene, three types of splicing
mutations  have  been  associated  with  autosomal  dominant
cataracts. And all three types were located in the first base in
intron 3. The first one is the IVS3+1 G→A mutation [14-16].
The second type of mutation is the IVS3+1 G→C [17,18]. In
2011, we identified the third type, the IVS3+1 G→T mutation,
in a Chinese family with suture cataracts [19]. This report,
indicating  the  IVS3+2  T→G,  will  be  the  fourth  type  of
splicing mutation as well as the first mutation found in the
second base of intron 3 in CRYBA1/A3.
Several mutations at the absolutely conserved intronic 5′-
gt or 3′-ag dinucleotide, at splice sites, have been identified in
various genetic disorders. Splice-site mutations usually lead
to  aberrant  pre-mRNA  splicing,  which  results  in  exon
skipping,  activation  of  cryptic  splice  sites,  creation  of  a
pseudo-exon within an intron, or intron retention [20]. There
has been little study of the mechanisms for normal pre-mRNA
splicing in CRYBA1/A3. In this study, the T at position +2 of
the 5′ (donor) splice site is highly conserved and mutation of
this base was shown to disrupt the splice site, causing intron
3 to be retained during pre-mRNA splicing (Figure 4B). As a
result of the mutation, the next 25 codons within the retained
intron 3 would be a UAG stop site (Figure 4C), and the
premature termination codon would cause truncated protein
that contains the first motif and an additional peptide with 24
amino acid residues. According to the previous study, it is not
possible to form even a single functional Greek key structure
without the second motif. This is because the fourth strand
that form the first motif is provided by the second motif, and
vice versa [12].
Consequently, the protein would be folded incorrectly
after  synthesis.  Not  only  would  this  improperly  folded
crystallin be unstable and serve as a nidus for precipitation of
other damaged proteins, but it might also interfere with other
appropriate associations of β-crystallin. Any of these events
would be likely to result in the formation of cataracts. This
suggests that the βA3-crystallin splice mutation might cause
the cataracts in this family.
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